GigaCyte Announces Opening of Large Capacity Class 10,000 Media Production Laboratory

Share Article

State of the art laboratory allows GigaCyte to optimize its drug discovery efforts through stem-cell research.

GigaCyte logo

The value of stem-cell models to researchers is highly limited without GigaCyte's culture media that are truly optimized for the specific cell types and unique lineage stages of each line.

GigaCyte, LLC., a leading provider of human stem cell-based products and preclinical contract research services, headquartered in Branford, Connecticut USA, announced today that they have completed construction and validation of their new Class 10,000 clean room facility for mass cell culture media production. This department, led by Richard Malavarca (former founder of Specialty Media Inc., now part of Millipore Inc.) has developed the next generation formulations of complete media products for the growth and differentiation into neuronal and hepatic cells and for the maintenance of the mature cell types. These complete media products are expected to fuel the continued growth of GigaCyte’s cellular products and CRO businesses.

“Rich’s extraordinary expertise with specialized media formulations coupled with his vast experience in scaling its production are the key ingredients to our company’s continued growth. The value of stem-cell models to researchers is highly limited without GigaCyte’s culture media that are truly optimized for the specific cell types and unique lineage stages of each line. Combining Rich’s world-class media team with our expertise in stem-cell and primary cells research has proven most effective in making these highly sought after model systems practical for industry,” said Shiloh Barfield, EVP/General Manager of GigaCyte, LLC.

“I am tremendously excited about our new media production laboratory. Its capacity has allowed us to increase accessibility of our formulations. Having a state of the art facility allows us to scale even further our ability to optimize the drug discovery efforts of our clients. I am very proud of the laboratory and the effects it is having to further enable this field of research.” said Richard Malavarca EVP of Media Production on GigaCyte’s new facility.

About Shiloh Barfield.
Mr. Barfield, was the Vice President of Sales & Marketing for the former venture capital based CellzDirect Inc., (the world’s leader for many years in hepatic drug development services and cell products which was purchased by Invitrogen, Inc. in February 2008 for $57M USD).

About Richard Malavarca.
Mr. Malavarca, was the founder of Specialty Media, a recognized leader in custom media production that was purchased by Millipore in 2005.

About GigaCyte LLC.
GigaCyte, LLC. is a privately held bioscience company that provides bio/pharmaceutical companies and research centers with innovative stem-cell tools, cell culture media and contract laboratory services focused primarily on basic research, drug discovery and preclinical development efforts. For additional information, please refer to the company's web site at http://www.gigacyte.com or email us at cellmedia@gigacyte.com or call 919.699.0033

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

GigaCyte, LLC
Visit website